The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is a controversial disease both in terms of clinical classification and choice of therapeutic strategy. Choroidal layers, retinal pigment epithelium (RPE), photoreceptors, and retina are involved to varying degrees. Beyond well-known symptoms raising the clinic...
Main Authors: | Stefano Da Da Da Pozzo, Pierluigi Iacono, Alessandro Arrigo, Maurizio Battaglia Battaglia Battaglia Parodi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/105 |
Similar Items
-
Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging
by: George Joseph Manayath, et al.
Published: (2018-01-01) -
Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy
by: Apoorva Ayachit, et al.
Published: (2018-01-01) -
Multimodal assessment of patients with chronic central serous chorioretinopathy
by: Karlos Ítalo Souza Viana, et al. -
Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy
by: Mehmet Yasin Teke, et al.
Published: (2014-04-01) -
Central serous chorioretinopathy misdiagnosed as posterior uveitis and the vicious circle of corticosteroid therapy
by: Marina Papadia, et al.
Published: (2015-01-01)